Capital Markets Day
Thursday 25th of June, 2026 | 9:00 AM EDT / 15:00 CEST
St. Regis Hotel, New York & Live Webcast
Featuring discussions with key opinion leaders and presentations by Hansa’s management team.
Click Here to Register & AttendThursday 25th of June, 2026 | 9:00 AM EDT / 15:00 CEST
St. Regis Hotel, New York & Live Webcast
Featuring discussions with key opinion leaders and presentations by Hansa’s management team.
Click Here to Register & AttendEn del av innehållet på denna sida finns endast tillgängligt på engelska. Allt material som krävs enligt tillämpliga lagar och förordningar finns tillgängligt på engelska och svenska.

20-HMedIdeS-19 Topline Results Post Authorization Efficacy Study (PAES)
Hansa Biopharma €115 Million Out Licensing of Idefirix in Europe and MENA to SERB
Hansa Biopharma Capital Markets Day
Interim Report for January-June 2026
Interim Report for January-September 2026
| 2026 | Presentation | Webcast |
|---|---|---|
27 maj 2026 20-HMedIdeS-19 Topline Results Post Authorization Efficacy Study (PAES) | ||
19 maj 2026 Hansa Biopharma €115 Million Out Licensing of Idefirix in Europe and MENA to SERB | ||
14 apr 2026 Hansa Biopharma Corporate Presentation April 2026 | ||
13 mar 2026 Leerink Global Healthcare Conference - Hansa Biopharma Fireside Chat | ||
13 mar 2026 Hansa Biopharma Corporate Presentation March 2026 | ||
11 feb 2026 Q4 Earnings Report 2025 Presentation | ||
12 jan 2026 Hansa Biopharma Corporate Presentation January 2026 |